Trials / Withdrawn
WithdrawnNCT03446222
Epicardial Mini-Maze Versus Catheter Ablation for the Management of Persistent Atrial Fibrillation
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- The University of Texas Health Science Center, Houston · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will assess the efficacy of catheter ablation versus the Wolf Mini-Maze surgical ablation for rhythm control in patients with persistent afib.
Detailed description
Higher success rates have been achieved after a single surgical ablation when compared to catheter ablation, however contiguous and transmural lesions are not always guaranteed. Even though, catheter ablation is now being offered for symptomatic persistent AF, recurrence after the index procedure in such a persistent AF substrate is not unusual. Redo-catheter ablation is routinely offered for such patients; however long term success still remains low. Non-pulmonary vein triggers are often targeted in such redo-catheter ablation procedures; though this approach remains controversial. More recently, the Wolf Mini-Maze procedure has been utilized with promising results. This study proposes to randomize a group of persistent AF patients to undergo either catheter ablation or the surgical mini-maze procedure with left atrial appendage (LAA) ligation
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Catheter ablation | Catheter based radiofrequency ablation with wide antral circumferential PVI and isolation of posterior wall will be performed. Mitral and cavo-tricuspid isthmus ablation will be done only if such isthumus dependent flutters are documented prior to / during the procedure. |
| PROCEDURE | Mini-maze surgical procedure | Wolf Mini-maze surgical ablation along with left atrial appendage ligation will be performed. |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2017-12-01
- Completion
- 2018-12-18
- First posted
- 2018-02-26
- Last updated
- 2018-02-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03446222. Inclusion in this directory is not an endorsement.